FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications

E-ISSN： 1873-4286|11|26|3449-3457

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.26, 2005-10, pp. : 3449-3457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-03 ,pp. : 255-271

Bentham Science Publishers

Access to resources Recommend Favorite

FLT3 as a Therapeutic Target in Childhood Acute Leukemia

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 703-714

Bentham Science Publishers

Access to resources Recommend Favorite

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

By Qu Shuang Liu Bin Guo Xiaoling Shi Hongshun Zhou Meifeng Li Li Yang Shulan Tong Xiuzhen Wang Haihe

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2130-2141

Blackwell Publishing

Access to resources Recommend Favorite

The clinical development of FLT3 inhibitors in acute myeloid leukemia

By Knapper Steven

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1377-1395

Informa Healthcare

Access to resources Recommend Favorite

Bench to Bedside Targeting of FLT3 in Acute Leukemia

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 781-789

Bentham Science Publishers

Access to resources Recommend Favorite